Dimitri Krainc

Active 1993–2025

110
Papers
24,841
Citations
73
h-index
106
i10-index

Citations

Citations per year for Dimitri Krainc1978: 1 citations1990: 4 citations1993: 2 citations1994: 21 citations1995: 25 citations1996: 51 citations1997: 70 citations1998: 74 citations1999: 85 citations2000: 51 citations2001: 59 citations2002: 58 citations2003: 86 citations2004: 83 citations2005: 88 citations2006: 126 citations2007: 144 citations2008: 147 citations2009: 143 citations2010: 176 citations2011: 237 citations2012: 284 citations2013: 335 citations2014: 334 citations2015: 320 citations2016: 301 citations2017: 362 citations2018: 401 citations2019: 1,044 citations2020: 1,246 citations2021: 1,255 citations2022: 1,006 citations2023: 733 citations2024: 1,198 citations2025: 567 citations2026: 15 citations1979–1989: no citations, so these years are not shown1991–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,695 citing papers, 29.1% of this breakdownChina: 1,282 citing papers, 10.1% of this breakdownUnited Kingdom: 912 citing papers, 7.2% of this breakdownGermany: 785 citing papers, 6.2% of this breakdownItaly: 593 citing papers, 4.7% of this breakdownCanada: 486 citing papers, 3.8% of this breakdownFrance: 372 citing papers, 2.9% of this breakdownJapan: 351 citing papers, 2.8% of this breakdownSpain: 321 citing papers, 2.5% of this breakdownIndia: 295 citing papers, 2.3% of this breakdownAustralia: 272 citing papers, 2.2% of this breakdownSouth Korea: 252 citing papers, 2% of this breakdown
0%29.1%Other 24.2%

Fields

  • Medicine45.4%
  • Biochemistry, Genetics and Molecular Biology32.7%
  • Neuroscience15.5%
  • Immunology and Microbiology1%
  • Veterinary0.8%
  • Engineering0.8%
  • Other3.8%

Topics

  • Parkinson's Disease Mechanisms and Treatments8.4%
  • Mitochondrial Function and Pathology5.8%
  • Autophagy in Disease and Therapy5.1%
  • Genetic Neurodegenerative Diseases3.6%
  • Alzheimer's disease research and treatments3.1%
  • Lysosomal Storage Disorders Research3%
  • Other71%

Coauthors

All papers

Open in search
  1. Mitochondria–lysosome contacts regulate mitochondrial fission via RAB7 GTP hydrolysis

    Authors: , , - Nature 2018 cited by 891

  2. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease

    Authors: , , , , , , , , , , , , , , , - Science 2017 cited by 887

  3. Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies

    Authors: , , , , , , , , - Cell 2011 cited by 1,344

  4. α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies

    Authors: , - Nature Medicine 2017 cited by 880

  5. Mitochondria-lysosome contacts regulate mitochondrial Ca 2+ dynamics via lysosomal TRPML1

    Authors: , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 cited by 324

  6. Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson’s Disease

    Authors: , , , , - Trends in Neurosciences 2018 cited by 324

  7. Regulation and Function of Mitochondria–Lysosome Membrane Contact Sites in Cellular Homeostasis

    Authors: , , , - Trends in Cell Biology 2019 cited by 345

  8. Human iPSC-Based Modeling of Late-Onset Disease via Progerin-Induced Aging

    Authors: , , , , , , , , , , , , , , , , - Cell stem cell 2013 cited by 768

  9. Functional Impairment in Miro Degradation and Mitophagy Is a Shared Feature in Familial and Sporadic Parkinson’s Disease

    Authors: , , , , , , , , , - Cell stem cell 2016 cited by 471

  10. Dysregulation of mitochondria-lysosome contacts by GBA1 dysfunction in dopaminergic neuronal models of Parkinson’s disease

    Authors: , , , - Nature Communications 2021 cited by 189

  11. α-Synuclein–induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models

    Authors: , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 393

  12. Parkin regulates amino acid homeostasis at mitochondria-lysosome (M/L) contact sites in Parkinson’s disease

    Authors: , , , , - Science Advances 2023 cited by 78

  13. Transcriptional Repression of PGC-1α by Mutant Huntingtin Leads to Mitochondrial Dysfunction and Neurodegeneration

    Authors: , , , , , - Cell 2006 cited by 997

  14. Dopamine metabolism by a monoamine oxidase mitochondrial shuttle activates the electron transport chain

    Authors: , , , , , , , , , , , , , - Nature Neuroscience 2019 cited by 184

  15. Increased Lysosomal Exocytosis Induced by Lysosomal Ca2+ Channel Agonists Protects Human Dopaminergic Neurons from α-Synuclein Toxicity

    Authors: , , , , , , , , , , , , , - Journal of Neuroscience 2019 cited by 162

  16. A call for transparent reporting to optimize the predictive value of preclinical research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Steve Perrin, John D. Porter, Oswald Steward, Ellis F. Unger, Ursula Utz, Shai D. Silberberg - Nature 2012 cited by 1,224

  17. Identification and Rescue of α-Synuclein Toxicity in Parkinson Patient–Derived Neurons

    Authors: , , , , , , , , , , , , , , , , , , , , , - Science 2013 cited by 461

  18. Defects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Cell 2004 cited by 1,161

  19. Activation of -Glucocerebrosidase Reduces Pathological -Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons

    Authors: , , , , , , , , , , - Journal of Neuroscience 2016 cited by 276

  20. Astrocytes Protect Human Dopaminergic Neurons from α-Synuclein Accumulation and Propagation

    Authors: , , , , , , , , , - Journal of Neuroscience 2020 cited by 115

  21. Key genes and convergent pathogenic mechanisms in Parkinson disease

    Authors: , - Nature reviews. Neuroscience 2024 cited by 82

  22. LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patients

    Authors: , , , , , , - Nature Communications 2019 cited by 196

  23. Genome-wide Association and Meta-analysis of Age at Onset in Parkinson Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marie‐Christine Chartier‐Harlin, Eugénie Mutez, Kathrin Brockmann, Angela Deutschländer, G. Hadjigeorgiou, Efthimos Dardiotis, Leonidas Stefanis, Athina Maria Simitsi, Enza Maria Valente, Simona Petrucci, Letizia Straniero, Anna Zecchinelli, Gianni Pezzoli, Laura Brighina, Carlo Ferrarese, Grazia Annesi, Andrea Quattrone, Monica Gagliardi, Lena F. Burbulla, Hirotaka Matsuo, Yusuke Kawamura, Nobutaka Hattori, Kenya Nishioka, Sun Ju Chung, Yun Joong Kim, Lukas Pavelka, Bart P.C. van de Warrenburg, Bastiaan R. Bloem, Andrew Singleton, Jan Aasly, Mathias Toft, Leonor Correia Guedes, Joaquim J. Ferreira, Soraya Bardien, Jonathan Carr, Eduardo Tolosa, Mario Ezquerra, Pau Pástor, Mónica Díez-Fairén, Karin Wirdefeldt, Nancy L. Pedersen, Caroline Ran, Andrea Carmine Belin, Andreas Puschmann, Clara Hellberg, Carl E Clarke, Karen Morrison, Dimitri Krainc, Matthew J. Farrer, Rejko Krüger, Alexis Elbaz, Thomas Gasser, Manu Sharma - Neurology 2022 cited by 71

  24. Sirt1 Mediates Neuroprotection from Mutant Huntingtin by Activation of TORC1 and CREB Transcriptional Pathway

    Authors: , , , , , , , , , - 2012 cited by 369